Myriad Genetics (MYGN) Cash from Investing Activities Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -188.86% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 2.46% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | 13.86% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | -59.07% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -48.84% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 64.36% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 41.86% |
| 10 | Myriad Genetics | 295.16 Mn | 170.76 Mn | 137.60 Mn | -29.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.82% |
| Dec 31, 2025 | 44.76% |
| Sep 30, 2025 | -36.51% |
| Jun 30, 2025 | 16.84% |
| Mar 31, 2025 | 41.43% |
| Dec 31, 2024 | 38.93% |
| Sep 30, 2024 | -70.46% |
| Jun 30, 2024 | -98.47% |
| Mar 31, 2024 | -42.04% |
| Dec 31, 2023 | -34.42% |
| Sep 30, 2023 | -27.02% |
| Jun 30, 2023 | -29.45% |
| Mar 31, 2023 | 14.25% |
| Dec 31, 2022 | 18.14% |
| Sep 30, 2022 | 53.34% |
| Jun 30, 2022 | -67.11% |
| Mar 31, 2022 | -121.51% |
| Dec 31, 2021 | -47.32% |
| Sep 30, 2021 | 44.91% |
| Jun 30, 2021 | -50.19% |